John Johnson insider trades
Open-market stock purchases and sales by John Johnson, Director at Axogen, Inc, from SEC Form 4 filings since Jan 31, 2011.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | AXGN Axogen, Inc | Bought (not open market) | — |
| Jun 19, 2026 | AXGN Axogen, Inc | Bought (not open market) | — |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc | Sold | $91.4K |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | — |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc | Bought (not open market) | $203K |
| May 21, 2026 | VSTM Verastem, Inc | Bought (not open market) | — |
| May 7, 2026 | AXGN Axogen, Inc | Sold | $478K |
| May 7, 2026 | AXGN Axogen, Inc | Bought (not open market) | — |
| Dec 19, 2025 | XERS Xeris Biopharma Holdings, Inc | Sold | $977K |
| Dec 9, 2025 | AXGN Axogen, Inc | Sold | $256K |
| Dec 9, 2025 | AXGN Axogen, Inc | Sold | $394K |
| Dec 9, 2025 | AXGN Axogen, Inc | Bought (not open market) | — |
| Dec 8, 2025 | AXGN Axogen, Inc | Sold | $369K |
| Dec 8, 2025 | AXGN Axogen, Inc | Sold | $371K |
| Dec 8, 2025 | AXGN Axogen, Inc | Bought (not open market) | — |
Companies traded
- AXGN Axogen, Inc: 6 sales, last Jun 24, 2026
- XERS Xeris Biopharma Holdings, Inc: 3 sales, last Jun 4, 2026
- VSTM Verastem, Inc: other filings, last May 21, 2026
- APLT Applied Therapeutics, Inc: other filings, last Dec 19, 2024
- SBBP Strongbridge Biopharma plc: other filings, last Oct 5, 2021
- PTLA Portola Pharmaceuticals Inc: other filings, last Jul 2, 2020
- MLNT Melinta Therapeutics, Inc /new/: 1 sale, last Jun 27, 2019
- HSGX Histogenics Corp: other filings, last Jun 15, 2018
- SCMP Sucampo Pharmaceuticals, Inc: other filings, last Feb 13, 2018
- AVEO Aveo Pharmaceuticals Inc: other filings, last Feb 1, 2018
- CEMP Cempra, Inc: 1 buy, last Jan 3, 2017
- DNDN Dendreon Corp: 1 buy, last Jul 3, 2014